The clinical trial studies the human pathogen of SARS-CoV-2, with a specificity in the circulating Spike 2 protein in the human system. The clinical trial hypothesizes that SARS-CoV-2 human pathogen arises from immune attacks, underlying the severe physiological symptoms that can be lethal. It further hypothesizes that the vaccines do not deal with the Spike 2 protein that causes the immune attacks.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
1
Due to initial availability of drugs and the intensities of the patient's symptoms, Nifedipine was used for initial intervention in preventing acute myocarditis from happening.
The diagnostic test has been used to confirm objective parameters to guide the intervention drug dosages and accessing the risks in sudden death and long term adverse effects.
The behavioral intervention aimed at reducing the risks of sudden and strong blood flows in the patient's system.
Residential Address
Chongqing, Chongqing Municipality, China
Heart Rate
The heart rate is monitored daily, and the primary goal is to stabilize the patient's heart rate.
Time frame: 1 day
Electrocardiogram
Electrocardiogram reflects the blood pressure management on the patient's health outcome and potential risks.
Time frame: 20 days
Platelet Distribution
Platelet distribution is measured to determine the viral induced blood-borne pathogen in the physiological responses of the patient.
Time frame: 10 days
Mean Platelet Volume
MPV is measured to determine the risks in blood clot and internal vein scratches in the patient.
Time frame: 10 days
Eosinophil Absolute Number
Eosinophil Absolute Number is measured to determine the intensities of infection in the patient.
Time frame: 10 days
Basophil Absolute Number
Basophil Absolute Number is measured on the counteraction of the patient's immune system integrities against the rapid acidification of the viral infection.
Time frame: 10 days
Cardiac Enzymes
Cardiac enzymes are measured to locate and eliminate the symptoms' causes, identify potential health risks, and to determine if subsidiary treatments are needed.
Time frame: 10 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The intervention aims to reduce the vein flows in Diastolic Blood Pressure, and the risks in blood clot formation and internal vein scratch bleeding.
The intervention aims to server the allergy-inducing proteins to induce renal hemodialysis.
Metoprolol Succinate is used to control the cardiac artery flow amounts and stabilize the patient's heart rate.
200 mg per day is used for supplement with the cardiac interventions.
The 268 mg twice per day dietary healthcare is the patient's usual daily use.
The 900 mg twice per day dietary healthcare is the patient's usual daily use.
Duloxetine hydrochloride is used for the patient's neurodiverse conditions.
Superoxide Dismutase is used to substitute the missing of antiviral drugs.